Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More people treated with Opdivo plus Yervoy reached the 6.5-year survival mark than those treated with either drug alone.
Study finds Black women had a worse prognosis following a breast cancer diagnosis.
Doctors are often reluctant to bring up advance care planning for people with advanced cancer, but doing so may increase optimism.
A five-year effort by Penn’s Abramson Cancer Center increased clinical trial enrollment of Black patients with cancer from 12% to 24%.
Young Black men who received PSA testing more often were 40% less likely to be diagnosed with advanced prostate cancer.
Cancer survival benefits in states with higher income eligibility limits for Medicaid were especially strong for early-stage breast cancer.
However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.